
    
      Randomized placebo controlled trial including COVID 19 seropositive patients will be treated
      with 30 gram per day for 4 weeks, compared to placebo group treated for the same duration in
      positive COVID 19 patients.

      Blood samples will be taken first at base line level, after two weeks and after the
      intervention after satisfying the inclusion and exclusion criteria. The main objective is to
      assess the effect of Gum Arabic (acacia Senegal) on immune system among COVID-19 patients.
      The outcome of this project understand SARS-CoV-2 immune response in COVID patients and the
      effect of Gum Arabic (Acacia Senegal) consumption to counteract progression of the disease
    
  